Background. Gram negative antibiotic resistance is increasing worldwide as both carbapenem-resistant enterobacteriaceae (CREs) and Enterobacteriaceae producing extended spectrum -lactamases (ESBLs) become more common.
References
[1]
Center for Disease Control and Prevention. 2013. Antibiotic/Antimicrobial Resistance; Threat Report 2013. Available at: http://www.cdc.gov/drugresistance/threat-report-2013/ (accessed 1 October 2013)
[2]
Munoz-Price LS, Hayden MK, Lolans K, Won S, Calvert K, Lin M, Stemer A, Weinstein RA. 2010. Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae at a long-term acute care hospital. Infection Control and Hospital Epidemiology 31(4):341-347
[3]
Naqvi A, Pulcini C. 2010. Bacterial resistance and antibiotic prescription: a survey of hospital physician perception, attitude, and knowledge. Medecine et Maladies Infectieuses 40(11):625-631
[4]
Nordmann P, Cuzon G, Naas T. 2009. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. The Lancet Infectious Diseases 9:228-236
[5]
Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. 2008. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infection Control and Hospital Epidemiology 29:1099-1106
[6]
Thibodeau E, Duncan R, Snydman DR, Bolstorff B, Vostok J, Barton K, Demaria A. 2012. Carbapenem-resistant Enterobacteriaceae (CRE): a statewide survey of detection in Massachusetts hospitals. Infection Control and Hospital Epidemiology 33(9):954-956
